Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR mHealth and uHealth

Date Submitted: Jun 23, 2024
Date Accepted: Feb 11, 2025
Date Submitted to PubMed: Mar 17, 2025

The final, peer-reviewed published version of this preprint can be found here:

SEARCH Study: Text Messages and Automated Phone Reminders for HPV Vaccination in Uganda: Randomized Controlled Trial

Kitaka SB, Rujumba J, Zalwango SK, Pfeffer B, Lubega K, Peninah NJ, Stephens AB, Barungi NN, Wynn CS, Babirye JN, Mukisa J, Mupere E, Stockwell MS

SEARCH Study: Text Messages and Automated Phone Reminders for HPV Vaccination in Uganda: Randomized Controlled Trial

JMIR Mhealth Uhealth 2025;13:e63527

DOI: 10.2196/63527

PMID: 40324213

PMCID: 12068829

SEARCH Study: SMS and Automated Phone Reminders for HPV Vaccination in Uganda: Randomized Controlled Trial

  • Sabrina B. Kitaka; 
  • Joseph Rujumba; 
  • Sarah K. Zalwango; 
  • Betsy Pfeffer; 
  • Kizza Lubega; 
  • Nattimba J Peninah; 
  • Ashley B. Stephens; 
  • Nicolette N Barungi; 
  • Chelsea S Wynn; 
  • Juliet N. Babirye; 
  • John Mukisa; 
  • Ezekiel Mupere; 
  • Melissa S Stockwell

ABSTRACT

Background:

Cervical cancer is currently the leading female cancer in Uganda. Most women are diagnosed with late-stage disease. Human papillomavirus (HPV) vaccination is the single most important primary preventive measure. While research regarding text message vaccine reminder use is strong in the U.S., their use has not yet been demonstrated in a pre-teen and adolescent population in Sub-Saharan Africa or other low- and middle-income countries.

Objective:

The objective of this pilot randomized controlled trial was to assess the impact of vaccine reminders with embedded interactive educational information on timeliness of HPV vaccination in Kampala, Uganda.

Methods:

In this randomized-controlled trial conducted in 2022, caregivers of adolescents needing a first or second HPV vaccine dose were recruited from an adolescent clinic and three community health centres in Kampala, Uganda. Families (n=154) were randomized 1:1 into intervention vs. usual care, stratified by dose (initiation, completion), language (English, Luganda) within each site. Intervention caregivers received a series of automated, personalized text messages or automated phone calls, based on family preference. Five messages were sent before the due date including both static and interactive educational information with five follow-up messages for those unvaccinated. Receipt of needed dose by 24 weeks post-enrolment was assessed by chi square, regression and Kaplan-Meier with log rank test. All analyses were intention-to-treat.

Results:

Overall, 154 caregivers enrolled (51.3% dose 1; 48.7% dose 2), and 64.3% spoke Luganda. Among the intervention arm, 62% requested text message and 38% automated phone reminders. There was no significant difference in requested mode by HPV vaccine dose or language. Intervention adolescents were more likely to receive a needed dose by 24 weeks (65.4% vs. 37.7%; p<0.001; RR 1.7 95% CI 1.2-2.4). There was no interaction by dose or language. There was no difference in vaccination by those requesting text message vs. phone reminders (65.3% vs 63.3%, p=0.86). The number needed to message for one additional vaccination was 3.6 (95% CI 2.3-8.2). Kaplan-Meier curves demonstrated more timely vaccination in the intervention arm (p<0.001).

Conclusions:

In this novel trial, text message and automated phone reminders were effective in promoting more timely HPV vaccination in this population. Clinical Trial: ClinicalTrials.gov Identifier: NCT05151367


 Citation

Please cite as:

Kitaka SB, Rujumba J, Zalwango SK, Pfeffer B, Lubega K, Peninah NJ, Stephens AB, Barungi NN, Wynn CS, Babirye JN, Mukisa J, Mupere E, Stockwell MS

SEARCH Study: Text Messages and Automated Phone Reminders for HPV Vaccination in Uganda: Randomized Controlled Trial

JMIR Mhealth Uhealth 2025;13:e63527

DOI: 10.2196/63527

PMID: 40324213

PMCID: 12068829

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.